Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten
June 30, 2023 01:00 ET
|
Biocartis NV
PERSBERICHT - GEREGLEMENTEERDE INFORMATIE 30 juni 2023, 7:00 CEST Openbaarmaking van uitstaande stemrechtverlenende effecten Mechelen, België, 30 juni 2023 – Biocartis Group NV (de "Vennootschap"...
Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities
June 30, 2023 01:00 ET
|
Biocartis NV
PRESS RELEASE - REGULATED INFORMATION 30 June 2023, 7:00 CEST Disclosure of Outstanding Voting Securities Mechelen, Belgium, 30 June 2023 – Biocartis Group NV (the "Company" or "Biocartis"), an...
AB Science reçoit un avis d’acceptation pour un brevet européen pour le masitinib dans le traitement du cancer de la prostate métastatique hormono-résistant (mCRPC)
June 26, 2023 12:11 ET
|
AB Science
COMMUNIQUE DE PRESSE AB SCIENCE REÇOIT UN AVIS D'ACCEPTATION POUR UN BREVET EUROPEEN POUR LE MASITINIB DANS LE TRAITEMENT DU CANCER DE LA PROSTATE METASTATIQUE HORMONO-RESISTANT (mCRPC),...
AB Science receives Notice of Allowance for European patent covering masitinib in the treatment of metastatic castrate refractory prostate cancer (mCRPC)
June 26, 2023 12:11 ET
|
AB Science
PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN PATENT COVERING MASITINIB IN THE TREATMENT OF METASTATIC CASTRATE REFRACTORY PROSTATE CANCER (mCRPC), STRENGTHENING THE COMPANY’S...
Persbericht Biocartis Group NV: Openbaarmaking van transparantiekennisgeving
June 20, 2023 11:40 ET
|
Biocartis NV
PERSBERICHT - GEREGLEMENTEERDE INFORMATIE20 juni 2023, 17:40 CEST Openbaarmaking van transparantiekennisgeving Mechelen, België, 20 juni 2023 – Biocartis Group NV (de ‘Vennootschap’ of ‘Biocartis’),...
Press release Biocartis Group NV: Disclosure of transparency notification
June 20, 2023 11:40 ET
|
Biocartis NV
PRESS RELEASE - REGULATED INFORMATION 20 June 2023, 17:40 CEST Disclosure of transparency notification Mechelen, Belgium, 20 June 2023 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an...
Persbericht Biocartis Group NV: Biocartis kondigt geplande operationele reorganisatie en kostenverminderingsprogramma aan
June 15, 2023 11:15 ET
|
Biocartis NV
PERSBERICHT GEREGLEMENTEERDE INFORMATIE – VOORWETENSCHAP15 juni 2023, 17:15 CEST BIOCARTIS KONDIGT GEPLANDE OPERATIONELE REORGANISATIE EN KOSTENVERMINDERINGSPROGRAMMA AAN Investeringen gefocust op...
Press release Biocartis Group NV: Biocartis announces planned operational reorganization and cost reduction program
June 15, 2023 11:15 ET
|
Biocartis NV
PRESS RELEASE REGULATED INFORMATION – INSIDE INFORMATION 15 June 2023, 17:15 CEST BIOCARTIS ANNOUNCES PLANNED OPERATIONAL REORGANIZATION AND COST REDUCTION PROGRAM Focusing...
Persbericht Biocartis Group NV: Openbaarmaking van transparantiekennisgeving
June 08, 2023 01:00 ET
|
Biocartis NV
PERSBERICHT GEREGLEMENTEERDE INFORMATIE 8 juni 2023, 7:00 CEST Openbaarmaking van transparantiekennisgeving Mechelen, België, 8 juni 2023 – Biocartis Group NV (de ‘Vennootschap’ of ‘Biocartis’),...
Press release Biocartis Group NV: Disclosure of transparency notification
June 08, 2023 01:00 ET
|
Biocartis NV
PRESS RELEASE REGULATED INFORMATION 8 June 2023, 7:00 CEST Disclosure of transparency notification Mechelen, Belgium, 8 June 2023 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative...